Check it: A New Approach to Controlling Chlamydia Transmission in Young People
Status: | Recruiting |
---|---|
Conditions: | Infectious Disease |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 15 - 24 |
Updated: | 9/14/2018 |
Start Date: | May 22, 2017 |
End Date: | December 31, 2022 |
Contact: | Patricia J Kissinger, PhD |
Email: | kissing@tulane.edu |
Phone: | 504-988-7320 |
A New Approach to Controlling Chlamydia Transmission in Young People
This study, named "Check it," is a bundled program for African American (AA) men ages 15-24
that includes community testing for chlamydia and gonorrhea, expedited treatment for subjects
who test positive and their female sexual contacts, and rescreening for these two sexually
transmitted infections.
that includes community testing for chlamydia and gonorrhea, expedited treatment for subjects
who test positive and their female sexual contacts, and rescreening for these two sexually
transmitted infections.
Participants (N=4854) will be recruited through community partners, at events and using
social marketing campaigns including advertisements, referrals from other participants,
social media, and a web based educational website (Web-Ed). After establishing eligibility,
written informed consent will be obtained. Subjects will complete a survey and provide a
urine specimen for chlamydia (Ct) and gonorrhea (GC) testing and will provide their preferred
contact information in order to be contacted about their test results. Men with negative
results will be contacted by Tulane study staff and will be informed of their results.
Results for men who are positive will be reported to a Louisiana Office of Public Health
(LA-OPH) study specific disease intervention specialist (DIS) who will notify the subject of
his positive results and engage in partners services per their standard protocols. Partner
services means that the subject will be asked to name and provide contact information about
his female sex partners from the past 60 days. These sex partners will then be notified that
they have been exposed to the infection and offered expedited treatment. The name of the
subject is not mentioned. The study will cover the cost of the medications for subjects who
test positive for either or both organism and their female sexual partners. Three months
after treatment, male subjects who were positive will be asked to be re-screened and if
positive, the DIS will conduct similar expedited treatment and partner services. Any subject
who provides consent for annual testing reminders will be reminded using their preferred
method of contact.
social marketing campaigns including advertisements, referrals from other participants,
social media, and a web based educational website (Web-Ed). After establishing eligibility,
written informed consent will be obtained. Subjects will complete a survey and provide a
urine specimen for chlamydia (Ct) and gonorrhea (GC) testing and will provide their preferred
contact information in order to be contacted about their test results. Men with negative
results will be contacted by Tulane study staff and will be informed of their results.
Results for men who are positive will be reported to a Louisiana Office of Public Health
(LA-OPH) study specific disease intervention specialist (DIS) who will notify the subject of
his positive results and engage in partners services per their standard protocols. Partner
services means that the subject will be asked to name and provide contact information about
his female sex partners from the past 60 days. These sex partners will then be notified that
they have been exposed to the infection and offered expedited treatment. The name of the
subject is not mentioned. The study will cover the cost of the medications for subjects who
test positive for either or both organism and their female sexual partners. Three months
after treatment, male subjects who were positive will be asked to be re-screened and if
positive, the DIS will conduct similar expedited treatment and partner services. Any subject
who provides consent for annual testing reminders will be reminded using their preferred
method of contact.
Inclusion Criteria:
- Identifies as African American or Black
- Identifies as male
- 15-24 years of age
- Lives or spends most of his time in Orleans Parish
- Had vaginal sex with at least one woman in the past 2 months
- Has not taken azithromycin in the past 7 days
Exclusion Criteria:
- Unwilling or unable to provide informed consent
- Unable to speak or understand English
- Previously enrolled in the study by self-report
We found this trial at
1
site
1440 Canal Street
New Orleans, Louisiana 70112
New Orleans, Louisiana 70112
Phone: 504-988-7320
Click here to add this to my saved trials